In this study, we firstly presented the up-to-date largest cohort of dynamic ctDNA profiling in HER2 mutant NSCLC on the basis of a prespecified biomarker analysis of two prospectively trials. Here, ERBB2 is linked to non-small cell lung carcinoma.